Experimental study on therapeutic effect of in vivo expression of Cell I-Hep II recombinant polypeptide of fibronectin on murine H22 hepatocellular carcinoma

Table 2 Inhibitory effect of pCH510 in combination with chemotherapy on murine tumor

Groups	n	Tumor weight (g, -x±s)
		d 11	d 21
A: control	8	2.12 ± 0.38
B: pCH510 (d 2 to d11)	8	0.82 ± 0.21 a
C: chemo I	8	0 a
D: chemo II	8		1.58 ± 0.31
E: MMC + pCH510 (d 2 to d 11)	8		1.49 ± 0.28
F: MMC + pCH510 (d 6 to d 20)	8		0.42 ± 0.12b

^aP < 0.01 vs control;

^bP < 0.01 vs chemo II.